IFNAR1 and head and neck squamous cell carcinoma: Moreover, the anti‐PD‐L1‐induced reductions in tumor volume and weight were completely abrogated by combined treatment with an anti‐IFNAR inhibitor, indicating that Type I IFN signaling is indispensable for ICB‐induced antitumor effects in HNSCC (Fig. 5A–D).